543 related articles for article (PubMed ID: 15113639)
1. Changes in drug utilization following the outpatient prescription drug cost-sharing program--evidence from Taiwan's elderly.
Liu SZ; Romeis JC
Health Policy; 2004 Jun; 68(3):277-87. PubMed ID: 15113639
[TBL] [Abstract][Full Text] [Related]
2. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
Liu SZ; Romeis JC
Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
[TBL] [Abstract][Full Text] [Related]
3. The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: own- and cross-price elasticities.
Li X; Guh D; Lacaille D; Esdaile J; Anis AH
Health Policy; 2007 Aug; 82(3):340-7. PubMed ID: 17134787
[TBL] [Abstract][Full Text] [Related]
4. The impact of nonreferral outpatient co-payment on medical care utilization and expenditures in Taiwan.
Chen LC; Schafheutle EI; Noyce PR
Res Social Adm Pharm; 2009 Sep; 5(3):211-24. PubMed ID: 19733822
[TBL] [Abstract][Full Text] [Related]
5. The effects of Taiwan's National Health Insurance on access and health status of the elderly.
Chen L; Yip W; Chang MC; Lin HS; Lee SD; Chiu YL; Lin YH
Health Econ; 2007 Mar; 16(3):223-42. PubMed ID: 16929478
[TBL] [Abstract][Full Text] [Related]
6. Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program.
Anderson GM; Kerluke KJ; Pulcins IR; Hertzman C; Barer ML
Inquiry; 1993; 30(2):199-207. PubMed ID: 8314608
[TBL] [Abstract][Full Text] [Related]
7. The effects of outpatient co-payment policy on healthcare usage by the elderly in Taiwan.
Huang JH; Tung CM
Arch Gerontol Geriatr; 2006; 43(1):101-16. PubMed ID: 16280181
[TBL] [Abstract][Full Text] [Related]
8. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.
Hartung DM; Carlson MJ; Kraemer DF; Haxby DG; Ketchum KL; Greenlick MR
Med Care; 2008 Jun; 46(6):565-72. PubMed ID: 18520310
[TBL] [Abstract][Full Text] [Related]
9. Doctor pharmaceutical utilization behaviour changed by the global budget programme strategies on hypertensive outpatient prescription.
Wei CK; Wang SM; Yeh MK
J Eval Clin Pract; 2012 Apr; 18(2):262-8. PubMed ID: 21040251
[TBL] [Abstract][Full Text] [Related]
10. The impact of co-payment increases on dispensings of government-subsidised medicines in Australia.
Hynd A; Roughead EE; Preen DB; Glover J; Bulsara M; Semmens J
Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1091-9. PubMed ID: 18942671
[TBL] [Abstract][Full Text] [Related]
11. Controlling prescription drug expenditures: a report of success.
Miller DP; Furberg CD; Small RH; Millman FM; Ambrosius WT; Harshbarger JS; Ohl CA
Am J Manag Care; 2007 Aug; 13(8):473-80. PubMed ID: 17685828
[TBL] [Abstract][Full Text] [Related]
12. Changes in drug prescription utilization for diabetic and hypertensive outpatients after initiation of the National Health Insurance's Global Budget Program in Taiwan.
Chou CC; Hu KY; Wu NR; Cheng YH; Loh CH; Yeh MK
Med Sci Monit; 2008 May; 14(5):PH33-39. PubMed ID: 18443560
[TBL] [Abstract][Full Text] [Related]
13. The effects of copayments and generic substitution on the use and costs of prescription drugs.
Smith DG
Inquiry; 1993; 30(2):189-98. PubMed ID: 8314607
[TBL] [Abstract][Full Text] [Related]
14. Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers.
Schneeweiss S; Soumerai SB; Maclure M; Dormuth C; Walker AM; Glynn RJ
Clin Pharmacol Ther; 2003 Oct; 74(4):388-400. PubMed ID: 14534526
[TBL] [Abstract][Full Text] [Related]
15. Adverse events associated with prescription drug cost-sharing among poor and elderly persons.
Tamblyn R; Laprise R; Hanley JA; Abrahamowicz M; Scott S; Mayo N; Hurley J; Grad R; Latimer E; Perreault R; McLeod P; Huang A; Larochelle P; Mallet L
JAMA; 2001 Jan 24-31; 285(4):421-9. PubMed ID: 11242426
[TBL] [Abstract][Full Text] [Related]
16. The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use.
Hansen RA; Schommer JC; Cline RR; Hadsall RS; Schondelmeyer SW; Nyman JA
Res Social Adm Pharm; 2005 Jun; 1(2):139-57. PubMed ID: 17138472
[TBL] [Abstract][Full Text] [Related]
17. Prescription drugs: issues of cost, coverage, and quality.
Copeland C
EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
[TBL] [Abstract][Full Text] [Related]
18. Effect of prescription benefit changes on medical care utilization in a Medicare HMO population.
Balkrishnan R; Byerly WG; Camacho FT; Shrestha A; Anderson RT
Am J Manag Care; 2001 Nov; 7(11):1093-100. PubMed ID: 11725812
[TBL] [Abstract][Full Text] [Related]
19. Patterns of combined prescriptions of aspirin-Ginkgo biloba in Taiwan: a population-based study.
Chang LC; Huang N; Chou YJ; Kao FY; Hsieh PC; Huang YT
J Clin Pharm Ther; 2008 Jun; 33(3):243-9. PubMed ID: 18452411
[TBL] [Abstract][Full Text] [Related]
20. Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia.
Morgan SG; Agnew JD; Barer ML
Health Policy; 2004 Jun; 68(3):299-307. PubMed ID: 15113641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
